Consistent with previous results, compared to infection alone, P3DEX treatment increased LC3B (−0.09 ± 0.2 vs. 0.02 ± 0.2; p = 0.05) (Figure 4D,E) and decreased p62 (−0.43 ± 0.27 vs. −0.55 ± 0.26; p = 0.02) expression (Figure 4D,F). The gene discussed is MAP1LC3B; the disease is infection.